(Q46921671)

English

Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Pooled analysis from the SPORTIF III and V studies

scientific article published on 5 January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Pooled analysis from the SPORTIF III and V studies (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

0 references

atrial fibrillation

1 reference

based on heuristic

inferred from title

Hans-Christoph Diener

1

object named as

Hans-Christoph Diener

1 reference

Europe PubMed Central

26 December 2017

author name string

Executive Steering Committee of the SPORTIFF III and V Investigators

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

publication date

5 January 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

Cerebrovascular Diseases

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

21

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

279-293

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

The Barthel ADL Index: a reliability study

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1159%2F000091265

21 January 2018

Identifiers

10.1159/000091265

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16449807

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46921671&oldid=2137931403"